TLDR On July 9, 2026, ARK Invest purchased 34,080 Meta Platforms shares valued at $20.55 million The strategic acquisition precedes Meta’s anticipated Q2 earnings announcement scheduled for J
Cathie Wood’s investment management firm, ARK Invest, executed several significant portfolio adjustments on Thursday, July 9, 2026. The most substantial transaction involved a $20.55 million stake increase in Meta Platforms through the ARK Innovation ETF.
The purchase encompassed 34,080 Meta shares, positioning ARK ahead of the social media giant’s upcoming second-quarter financial results disclosure on July 29.
Analyst projections suggest Meta will deliver earnings of $7.17 per share alongside revenue totaling $60.19 billion for the reporting period.
The investment decision follows a series of significant artificial intelligence developments from Meta. The tech giant introduced Muse Spark 1.1, marking its entry into paid AI model offerings, and rolled out innovative AI-powered business tools.
Meta has also announced that Iris, its proprietary AI semiconductor, will enter large-scale production this September. Additionally, the company revealed plans for a substantial capital commitment exceeding $13 billion toward constructing a cutting-edge data center facility in Alberta, Canada.
According to TipRanks, Meta receives a Strong Buy consensus recommendation derived from 34 Buy ratings alongside five Hold ratings. The consensus price target of $817.15 suggests potential upside of approximately 29.4% from present trading levels. Year-to-date, Meta shares have declined 4.2%.
Concurrently, ARK liquidated 10,774 Advanced Micro Devices shares through its ARKK ETF, representing $5.57 million in value. This transaction extends a recent pattern of AMD position reduction spanning multiple trading sessions.
The investment firm also divested 85,319 Robinhood Markets shares valued at $9.69 million and offloaded 70,154 Roku shares worth $9.77 million.
ARK further reduced its Twist Bioscience holdings by selling 98,776 shares, generating proceeds of $8.83 million.
Beyond the Meta acquisition, ARK expanded its Circle Internet Group exposure by purchasing 217,896 shares distributed across its ARKK, ARKW, and ARKF ETFs, representing a combined investment of $13.96 million.
Additional accumulation included 105,364 Ionis Pharmaceuticals shares for $8.9 million and 544,385 Prime Medicine shares totaling $2.52 million.
Minor acquisitions encompassed 57,462 Generate Biomedicines shares valued at $911,921 and 46,302 Compass Pathways shares worth $646,838.
Following disclosure of ARK’s purchase activity, Meta stock advanced 6.58% on July 10.
The post ARK Invest Pours $20M Into Meta (META) While Dumping AMD Stock appeared first on Blockonomi.
